MetLife Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-21,270
| Closed | -$1.98M | – | 2795 |
|
|
2021
Q4 | $1.98M | Hold |
21,270
| – | – | 0.02% | 873 |
|
|
2021
Q3 | $1.27M | Sell |
21,270
-1,649
| -7% | -$97.4K | 0.01% | 1020 |
|
|
2021
Q2 | $1.56M | Hold |
22,919
| – | – | 0.01% | 965 |
|
|
2021
Q1 | $1.59M | Hold |
22,919
| – | – | 0.01% | 951 |
|
|
2020
Q4 | $1.76M | Sell |
22,919
-1,495
| -6% | -$112K | 0.02% | 887 |
|
|
2020
Q3 | $1.83M | Hold |
24,414
| – | – | 0.02% | 756 |
|
|
2020
Q2 | $1.54M | Buy |
24,414
+3,513
| +17% | +$193K | 0.02% | 837 |
|
|
2020
Q1 | $878K | Sell |
20,901
-1,589
| -7% | -$72.9K | 0.01% | 963 |
|
|
2019
Q4 | $1.02M | Hold |
22,490
| – | – | 0.01% | 1092 |
|
|
2019
Q3 | $1.03M | Hold |
22,490
| – | – | 0.01% | 1054 |
|
|
2019
Q2 | $1.32M | Hold |
22,490
| – | – | 0.01% | 988 |
|
|
2019
Q1 | $1.01M | Hold |
22,490
| – | – | 0.01% | 1081 |
|
|
2018
Q4 | $876K | Hold |
22,490
| – | – | 0.01% | 1073 |
|
|
2018
Q3 | $1.03M | Hold |
22,490
| – | – | 0.01% | 1105 |
|
|
2018
Q2 | $981K | Hold |
22,490
| – | – | 0.01% | 1023 |
|
|
2018
Q1 | $888K | Buy |
22,490
+3,799
| +20% | +$148K | 0.01% | 1057 |
|
|
2017
Q4 | $635K | Buy |
+18,691
| New | +$532K | 0.01% | 1266 |
|
MetLife Investment Management's ARNA Position: Q1 2022 in Review
MetLife Investment Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 21,270 shares — an estimated $1.98M sold.
MetLife Investment Management first reported a position in ARNA in Q4 2017 and held it in 17 quarters. The position peaked at $1.98M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- MetLife Investment Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- MetLife Investment Management sold 21,270 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.98M.
- MetLife Investment Management first reported a position in Arena Pharmaceuticals Inc in Q4 2017 and held it in 17 quarters.
- MetLife Investment Management's Arena Pharmaceuticals Inc position peaked at $1.98M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.